FDA Notices of Judgment Collection, 1908-1966

856. Adulteration and misbranding of cascara compound tablets and Pentabisarsen ampuls. U. S. v. Max Gold and Irving Levine (Gold Leaf Pharmacal Co.). Plea of guilty. Fine, $500 on counts 2 and 4. Sentence suspended and defendants placed on probation for 1 year on counts 1 and 3.